Endari Will Be a New Specialty Med for Sickle Cell Disease

Endari (en-DAR-ee, L-glutamine) is the first sickle cell treatment to be approved in almost 20 years.

Endari works by stopping "sickle-shaped" red blood cells from blocking blood flow...which helps prevent pain crises, organ damage, and other symptoms.

It'll likely be saved for patients who are already on max doses of hydroxyurea...and still have 2 or more pain crises per year.

Get unlimited access through an Enterprise license

Hospital Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals